Immune Responses Against SARS-CoV-2 Variants after Two and Three Doses of Vaccine in B-cell Malignancies: UK PROSECO Study
Sean H. Lim,Beth Stuart,Debora Joseph-Pietras,Marina Johnson,Nicola Campbell,Adam Kelly,Danielle Jeffrey,Anna H. Turaj,Kate Rolfvondenbaumen,Celine Galloway, Thomas Wynn,Adam R. Coleman, Benjamin Ward, Karen Long, Helen Coleman,Carina Mundy,Andrew T. Bates, Diana Ayres,Robert Lown, Janlyn Falconer, Oliver Brake,James Batchelor,Victoria Willimott,Anna Bowzyk Al-Naeeb,Lisa Robinson,Ann O’Callaghan,Graham P. Collins,Tobias Menne,Saul N. Faust,Christopher P. Fox,Matthew Ahearne,Peter W. M. Johnson,Andrew J. Davies,David Goldblatt Nature Cancer（2022）
Key words
Cancer,Lymphoma,SARS-CoV-2,Vaccines,Life Sciences,general
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper